- Home
- ABEV vs CAH Comparison
ABEV vs CAH Comparison
Compare ABEV & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEV | CAH |
|---|---|---|
| Founded | 1885 | 1979 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Other Pharmaceuticals |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4B | 49.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEV | CAH |
|---|---|---|
| Price | $3.07 | $224.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $2.53 | ★ $229.09 |
| AVG Volume (30 Days) | ★ 27.9M | 1.8M |
| Earning Date | 02-12-2026 | 02-05-2026 |
| Dividend Yield | ★ 6.17% | 0.93% |
| EPS Growth | 8.28 | ★ 29.45 |
| EPS | 0.18 | ★ 6.94 |
| Revenue | $16,020,781,943.00 | ★ $244,673,000,000.00 |
| Revenue This Year | $9.59 | $16.99 |
| Revenue Next Year | $5.36 | $9.27 |
| P/E Ratio | ★ $17.33 | $31.79 |
| Revenue Growth | N/A | ★ 10.08 |
| 52 Week Low | $1.84 | $120.72 |
| 52 Week High | $3.23 | $230.81 |
Technical Indicators
Market Signals| Indicator | ABEV | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 68.18 | 58.18 |
| Support Level | $2.88 | $213.75 |
| Resistance Level | $3.23 | $229.15 |
| Average True Range (ATR) | 0.06 | 7.01 |
| MACD | 0.02 | 0.17 |
| Stochastic Oscillator | 61.96 | 75.20 |
Price Performance
Historical ComparisonAbout ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.